Infectious Outcomes in Combat-Related Trauma

Combat-related injuries often produce extensive soft-tissue damage, open fractures and burn wounds that create an ideal nidus for microbial invasion. In austere environments where rapid evacuation and advanced surgical care may be delayed, the incidence of wound infection, osteomyelitis and invasive fungal disease rises markedly. The spectrum of pathogens encompasses multidrug-resistant bacteria such as Acinetobacter baumannii and Klebsiella pneumoniae, methicillin-resistant Staphylococcus aureus, and emerging hypervirulent strains. Antimicrobial resistance evolves under the dual pressures of mass casualty events and disrupted health infrastructures, complicating empirical therapy and prolonging hospital stays. Successful management requires integration of rapid diagnostics, tailored antibiotic stewardship and modular infection-prevention protocols deployable in forward operating bases. Insights gained from military cohorts have informed clinical practice guidelines and driven innovation in point-of-care molecular assays, with transferability to civilian trauma centres in regions affected by armed conflict.

Research from Nature Portfolio

Recent studies have illuminated the profound role of armed conflict in accelerating antimicrobial resistance. Analyses of conflict-associated healthcare disruptions reveal that breakdowns in surveillance and antibiotic stewardship permit unchecked dissemination of resistance determinants. Field laboratories equipped with rapid sequencing have begun to map transmission pathways, enabling more targeted control measures even amid active hostilities. Moreover, dedicated stewardship initiatives integrated into medical evacuation workflows have demonstrated reductions in broad-spectrum antibiotic use without compromising patient outcomes. These findings underscore the feasibility of embedding antimicrobial-resistance countermeasures within military medical systems and adapting them to civilian relief operations.

Infectious Outcomes in Combat-Related Trauma publication trend

The graph below shows the total number of articles in infectious outcomes in combat-related trauma across all publications each year (not limited to Nature Index journals).

Technical terms

Antimicrobial resistance: The ability of microorganisms to survive exposure to drugs that would normally inhibit or kill them, often due to genetic adaptations.

Multidrug-resistant organism (MDRO): A pathogen resistant to multiple antimicrobial classes, rendering standard treatments ineffective.

Osteomyelitis: Infection of bone tissue, frequently arising from direct inoculation in open fractures or contiguous spread from soft-tissue wounds.

Carbapenemase: An enzyme produced by certain bacteria that degrades carbapenem antibiotics, conferring high-level resistance.

Metallo-β-lactamase: A subclass of carbapenemases requiring zinc ions to hydrolyse β-lactam antibiotics, including last-resort agents.

References

1. The contribution of human conflict to the development of antimicrobial resistance. Communications Medicine (2023).
2. Pandrug-resistant Klebsiella pneumoniae isolated from Ukrainian war victims are hypervirulent. Journal of Infection (2024).
3. Increase in NDM-1 and NDM-1/OXA-48-producing Klebsiella pneumoniae in Germany associated with the war in Ukraine, 2022. Eurosurveillance (2022).
4. Infection with high proportion of multidrug-resistant bacteria in conflict-related injuries is associated with poor outcomes and excess resource consumption: a cohort study of Syrian patients treated in Jordan. BMC Infectious Diseases (2018).